Hemolytic anemia in a patient with hypertrophic obstructive cardiomyopathy  by Kubo, Toru et al.
Journal of Cardiology (2010) 55, 125—129
avai lab le at www.sc iencedi rec t .com
journa l homepage: www.e lsev ier .com/ locate / j j cc
CASE REPORT
Hemolytic anemia in a patient with hypertrophic
obstructive cardiomyopathy
Toru Kubo (MD), Hiroaki Kitaoka (MD, FJCC), Yasunobu Terauchi (MD),
Shinjiro Tamura (MD), Makoto Okawa (MD), Naohito Yamasaki (MD),
Toshikazu Yabe (MD), Yoshinori L. Doi (MD, FJCC) ∗
Department of Medicine and Geriatrics, Kochi Medical School, Kochi, Japan
Received 26 January 2009; received in revised form 25 February 2009; accepted 31 March 2009
Available online 9 May 2009
KEYWORDS
Hypertrophic
obstructive
cardiomyopathy;
Hemolytic anemia;
Hemodynamics
Summary A 66-year-old woman was referred for further evaluation and treatment of normo-
cytic and normochromic anemia with hemoglobin level of 8.6 g/dL. A peripheral blood smear
showed fragmented erythrocytes. The patient was then referred to the department of cardiol-
ogy because of systolic murmur, ECG abnormality, and red cell fragmentation. Transthoracic
echocardiography revealed hypertrophic cardiomyopathy with particularly increased inter-
ventricular septal thickness of 24mm and a hyperkinetic wall motion, resulting in marked
obstruction to left ventricular outﬂow tract (pressure gradient of 200mmHg). Mitral regur-
gitation due to systolic anterior motion of the mitral valve leaﬂets was also seen. The cause of
anemia was thought to be mechanical intravascular hemolysis due to left ventricular outﬂow
tract obstruction and mitral regurgitation. She was treated with atenolol and the class Ia antiar-
rhythmic drug cibenzoline to relieve the outﬂow tract obstruction, and the pressure gradient
was reduced to 70mmHg. After 3 months of treatment, her hemoglobin level had increased to
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IntroductionHypertrophic cardiomyopathy (HCM) is a heterogeneous
myocardial disorder with a broad spectrum of clinical
presentations and morphologic features [1]. Left ventric-
ular outﬂow tract (LVOT) obstruction does play a major
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diology. Published by Elsevier Ireland Ltd. All rights reserved.
ole in the pathophysiology of a subgroup of patients
ith HCM, and is associated with exercise intolerance due
o dyspnea or angina, and with cardiovascular mortality
2—4]. Here, we report a patient with electrocardiogra-
hy (ECG) abnormality who was referred to our hospital
or evaluation of anemia. The anemia was due to red
ell fragmentation caused by dynamic obstruction to LV
utﬂow, which led to the diagnosis of HCM. After 3
onths of treatment with atenolol and the class Ia
ntiarrhythmic drug cibenzoline, which has a negative
notropic action, she made a full recovery from her anemia
5].
Published by Elsevier Ireland Ltd. All rights reserved.
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7igure 1 Peripheral blood smear showing fragmented ery-
hrocytes.
ase report
n November 2006, a 66-year-old woman with a history of
ild hypertension and ECG abnormality was referred to the
epartment of hematology in our university hospital for
urther evaluation and treatment of normocytic and nor-
ochromic anemia. She received a blood transfusion at the
emoglobin level of 5.1 g/dL in the previous hospital. There
as no remarkable ﬁnding of gastrointestinal or uterine dis-
ase.
At the outpatient clinic, she had abnormal laboratory
est results showing a low hemoglobin level (8.6 g/dL), high
actate dehydrogenase (LDH) level (465U/L), high reticulo-
yte ratio (3.1%), and low haptoglobin level. The results of
oombs’ test and cold agglutination tests were negative.
esults of other laboratory tests, including ferritin, serum
ron, and folic acid tests, were all within normal ranges.
peripheral blood smear showed fragmented erythrocytes
Fig. 1). The patient was then referred to the department
f cardiology because of systolic murmur, ECG abnormal-
ty [Fig. 2; sinus tachycardia, complete right bundle branch
lock, left axis deviation, and abnormal Q waves in I, aVL
nd V4 (abnormal Q wave was deﬁned as more than or equal
o 0.04 s in duration or one-fourth of the ensuing R-wave in
epth)], and red cell fragmentation.
Her blood pressure was 130/60mmHg and a grade IV
ystolic ejection murmur was audible at the left third
ntercostal space near the left sternal border. Periph-
ral edema was not found. Chest X-ray showed a high
ardiothoracic ratio of 56% but no signs of congestion.
ransthoracic echocardiography revealed LV hypertrophy
ith particularly increased interventricular septal thick-
ess of 24mm and a hyperkinetic LV wall motion, resulting
n marked obstruction to LVOT (the velocity is 7.1m/s,
orresponding to the peak pressure gradient of 200mmHg
ith the simpliﬁed Bernoulli equation) (Fig. 3 a and b).
itral regurgitation due to systolic anterior motion of the
itral valve leaﬂets was also seen, although the mitral
alve itself showed no organic change (Fig. 3c). Diag-
osis of HCM with obstruction was made. The cause of
nemia was thus thought to be mechanical intravascular
c
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iigure 2 Electrocardiogram showing abnormal Q waves.
emolysis due to LVOT obstruction and mitral regurgita-
ion. She was treated with atenolol (25mg/day) and LVOT
ressure gradient was reduced to 130mmHg. An additional
reatment of the class Ia antiarrhythmic drug cibenzoline
150mg/day→ 300mg/day), which has a negative inotropic
ction, was commenced to relieve the outﬂow tract obstruc-
ion, and the pressure gradient was ﬁnally reduced to
0mmHg. After 3 months of treatment in the outpatient
linic, her hemoglobin level had increased to 11.4 g/dL with-
ut additional treatment for anemia (Fig. 4). Her symptoms
chest oppression and shortness of breath) improved signif-
cantly.
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Figure 3 (a) Transthoracic echocardiography showing increased interventricular septal thickness of 24mm. Yellow arrows indicate
increased septal thickness. (b) Doppler examination showing marked obstruction to left ventricular outﬂow tract (pressure gradient
of 200mmHg). (c) M-mode echocardiography showing systolic anterior motion (SAM) of the mitral valve leaﬂets. Red arrows indicate
SAM. (For interpretation of the references to color in this ﬁgure legend, the reader is referred to the web version of the article.).
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Rigure 4 Treatment and the change in left ventricular outﬂo
iscussion
ed cell fragmentation is one of the causes of hemolytic ane-
ia. The occurrence of valve-related mechanical hemolysis,
articularly prosthetic mitral valve regurgitation, has been
ell recognized [6,7]. On the other hand, there have been
nly four case reports of severe hemolytic anemia in patients
ith HCM [8—11]. In three of these case reports, hemolytic
nemia was often associated with infective endocardi-
is in the presence of LVOT obstruction [8—10]. However,
ur patient had no sign of infection and transesophageal
chocardiography did not show any evidence of infective
ndocarditis.
HCM is a primary disease of cardiac muscle that is char-
cterized by a hypertrophied, nondilated LV unassociated
ith other cardiac diseases [1]. HCM is now recognized to
omprise a wide spectrum of disease processes, with varying
enetics, morphology, functions, and prognosis. The clinical
resentations of HCM vary from an asymptomatic and benign
linical course to sudden premature death. Obstruction
o LV outﬂow is an important pathophysiological compo-
ent of this disease [2—4]. Dynamic subaortic gradients can
e induced with provocations by drugs (dobutamine, iso-
roterenol, digitalis, amyl nitrite), exercise, dehydration,
alsalva maneuver, and premature ventricular contractions.
nemia is also one of the provocative factors, which leads to
achycardia and increased ventricular contractility for the
equirements of the peripheral tissues for oxygen. In this
ase, LVOT obstruction caused hemolytic anemia which fur-
her increases ventricular contractility and causes severe
utﬂow tract obstruction. The resulting obstruction further
eads to decompensated hemolytic anemia. We consider
hat a vicious obstruction-anemia circle is thus established.
ttention should be given to dynamic left ventricular out-
ow obstruction itself in patients with HCM, which can cause
echanical hemolytic anemia due to red cell fragmenta-
ion.ct pressure gradient (LVOT-PG) and hemoglobin levels.
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